About bioVidria

 

bioVidria, inc. is focused on new materials for protein analysis to advance pharmaceuticals, proteomics, and agriculture. The core technology of the company is colloidal silica with specialized coatings to direct each application.

The company was founded at the University of Arizona in Tucson, Arizona by Dr. Mary Wirth. Dr. Wirth has published a broad portfolio of articles in a variety of scholarly journals and her work in analytical chemistry has earned her many national awards. Her work also has received over 30 federal research grants during her academic career. The company is now located at the Purdue Research Foundation, a biotech and high technology business center attached to Purdue University.

Product Development Portfolio

bioVidria, inc. is focused on new materials for protein analysis to advance pharmaceuticals, proteomics, and agriculture. The core technology of the company is colloidal silica with specialized coatings to direct each application. The product portfolio includes UHPLC capillaries for reversed phase LCMS, and immunobeads for trace protein pre-concentration from serum.

Company Leadership

Founded by Dr. Wirth, the company has a strong core of professionals drawing from a variety of industries including biotechnology, medical devices, material sciences, and high technology. Their combined expertise at developing and introducing breakthrough products and desire to bring to researchers a breadth of solutions to their daily challenges assures success going forward.

If you are interested in learning more about the company, please contact us at company@biovidria.com